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Because decision modeling involves the construction of an 
explicit, mathematically describable structure of the perti- 
nent elements of a clinical problem, the relative effective- 
ness of alternative approaches to care can be identified; 
costly procedures become apparent; new technologies can 
be assessed in relation to the old in terms of effectiveness 
and costs; the marginal benefit to be achieved by duplica- 
tive or alternative practices can be determined. All of this 
can be accomplished in terms of patient outcome and 
without the bias and self-interest of which the profession 
Role of Quantitation in Quality Care 
Medicine is the art of understanding diseases and of curing or 
relieving them when possible. Under this acceptation our 
sciences would, at least, be exonerated from reproach and 
would stand on a basis capable of supporting a reasonable 
and durable system for the amelioration of human mala- 
dies. 
Dr. Jacob Bigelow (1) 1852 
In paraphrase of what Bigelow (1) stated 137 years ago, 
medical practices and technology utilization presented in 
terms of patient outcome and with quantitative demonstra- 
tions of effectiveness would provide the structure for a 
reasonable and durable system of health care. 
It is the thesis underlying this presentation that quantita- 
tive analyses of those practices most likely to achieve 
optimal patient outcome and application of the findings to 
patient care are basic to “quality” care. Quantitation is the 
key word. Although there is a voluminous number of pub- 
lished reports on quality care, what it comprises and how to 
assess it, and physicians have always understood it to be 
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has been accused. Furthermore, if a resource allocation or 
reimbursement decision made in the name of cost contain- 
ment eliminates or limits access to effective diagnostic or 
therapeutic technologies, the impact of that decision on 
effective care can be explicitly and quantitatively expressed 
through decision modeling. When such analyses are based 
on patient outcome, they are difficult to ignore and provide 
a pivotal point for discussions and eventual compromise. 
(J Am Co11 Cardiol1989;14:7A-1IA) 
synonymous with effective and efficient care, without struc- 
ture, it is difficult to reach agreement on its definition, 
content, delivery mechanisms and criteria for assessment. 
When quality care is presented as a quantitative model based 
on effectiveness. however, a basis is provided for highlight- 
ing and discussing areas of agreement or disagreement 
without ambiguity and bias and, thus. for laying a foundation 
for rational decision making and resource allocations by 
physicians, nonmedical health care personnel and policy- 
makers alike. 
Benefits of assessing care in relation to effectiveness (patient 
outcome). The advantages accruing from assuming pre- 
eminence for effectiveness, quantitatively described in terms 
of patient outcome, as the most important descriptor of 
quality care are: optimal outcome is that which the public 
desires and considers to be quality care, and a common 
language is created that professionals, the public and poli- 
cymakers can understand; quantitative data on the options 
and choices that were considered in the decision-making 
processes relative to their care help patients understand their 
care and its costs and provide a basis for their choices; 
quality care can be best defended when management alter- 
natives are quantitatively related to outcome because the 
issues become clear and accusations of self-interest or other 
secondary gain are nullified; adequacy of diagnosis, physi- 
cian skill and discrimination in obtaining appropriate and 
complete information, soundness in evaluating data, choice 
of specific therapeutic regimens with due regard to risks, 
patient understanding and adequate surveillance can be 
related to optimal patient outcome. Most importantly, the 
need for specific technologies in order that quality care can 
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extracts of human skull, although expensive, were essential 
for quality care because they had significantly increased the 
king’s chances for survival; if bezoar stones, extracts of 
human skull or dissolved pearls were denied to the peasants 
by the Royal Health Service because of cost, a good case 
could be made by their physician advocates that quality care 
was being infringed upon. On the other hand, if bezoar 
stones accounted for the greatest percent cost of the total 
care, but contributed only a 1% additional probability for 
survival over the other therapies, singly or in combination, 
the policymakers in the king’s court would have data on 
which to structure their discussions and eventual decisions 
on the provision of bezoar stones for general population use 
on whether or not quality care would be significantly affected 
by the denial of bezoar therapy. Certainly, other physicians 
reading about the king’s care would have the benefit of 
having what the royal physicians thought was optimal care 
and their own thinking would have been influenced. 
Although the effectiveness of care approach is based on 
process of care criteria in that the selection of management 
alternatives and their execution are processes, the processes 
are more directly outcome-oriented than are process of care 
“standards” that are disease-oriented rather than patient- 
oriented. The “best” care is care that gives the greatest 
probability, in quantitative terms, of achieving the desired 
patient outcome, the values of which may be as diverse as 
mortality, morbidity, patient satisfaction, rehabilitation or 
cost, among others. The validity of the model would, of 
course, need to be assessed for accuracy through compari- 
sons with outcome data. 
The strongest argument for outcome-based criteria, over 
and above the fact that improved health (and patient satis- 
faction) are the goals of health care, is that the definition of 
quality care as effective (and efficient) care will “work.” 
Because it allows an unbiased quantitative explanation of 
why it is physicians do what they do, it will have a profound 
effect on “how doctors behave, on relations within the 
profession . . .” (4), and through improving relation among 
the profession, government, third party payers and manag- 
ers on reimbursement and resource allocation decisions. 
A Current Management Problem: Early 
Acute Myocardial Infarction 
Moving rapidly forward in time to our present decade, it 
is not difficult to identify high cost clinical practices, partic- 
ularly in cardiology, that should be subjected to decision 
modeling not only in defense of quality care, but to provide 
guidance as to the cost-effectiveness of alternative manage- 
ment strategies. One that comes immediately to mind is the 
management of the patient early in the course of acute 
myocardial infarction. 
There is increasing evidence that thrombolysis or other 
forms of revascularization are effective therapies and 
achieve a significant reduction in short-term mortality. How- 
ever, with wide application, the costs will be enormous. 
Furthermore, the complications are not trivial: bleeding of 
enough severity to require transfusion, cerebrovascular ac- 
cidents, acute occlusion requiring emergency bypass sur- 
gery, and death. In addition, the effectiveness of revascular- 
ization attempts may be only in the 65% range or as low as 
30% to 35%, depending on the time thrombolysis or other 
revascularization attempts are made relative to the onset of 
symptoms and other variables. In addition, there is a signif- 
icant incidence of restenosis and reinfarction after interrup- 
tion of the initial acute event so that early interventions may 
need to be followed up by coronary cineangiography and 
revascularization, if feasible. 
The clinical problem presented by early acute myocardial 
infarction is one that is ripe for decision modeling. The 
government and other reimbursement agencies are going to 
want information on the cost-effectiveness of thrombolysis 
or angioplasty, or both, and cardiologists’ “opinion,” no 
matter how many experts participate in its formulation, is 
not going to satisfy. The costs are simply too enormous. 
A Decision Model: Early Acute 
Myocardial Infarction 
A still evolving decision analysis of early acute myocar- 
dial infarction done in conjunction with Robert Dittus at the 
Regenstrief Institute for Health Care serves to illustrate the 
advantages (and disadvantages) of decision modeling. The 
analysis modeled 50 to 60 year old men with myocardial 
infarction who presented to a medical facility within the first 
4 h after the onset of symptoms. The model characterized 
patients with respect to coronary anatomy and estimated 
cardiovascular function, based on previous history of myo- 
cardial infarction, at the onset of their infarction and mod- 
eled the probabilities for living or dying and for the devel- 
opment of angina, congestive heart failure and reinfarction, 
while at the same time accruing costs for each management 
strategy in the hospital and at 1 year. 
The management alternatives were medical therapy, 
streptokinase, recombinant tissue-type plasminogen activa- 
tor (rt-PA), angioplasty or coronary artery bypass surgery. 
The strategies also included options if symptoms recurred 
after the first management choice. Therefore, there could be 
streptokinase followed by medical therapy: rt-PA and later 
medical therapy; t-t-PA and later angioplasty; streptokinase 
and later angioplasty and so forth. 
The data used were derived from large clinical trials 
and expert opinion. The preliminary results are shown in 
Table 1. 
If one eliminates bypass surgery as an exceedingly costly 
and morbidity-inducing strategy, the initial use of angio- 
plasty followed by angioplasty for recurrent symptoms or to 
maximize the probability for maintaining patency achieved 
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Table 1. One Year Mortality Rate Probabilities With Differing 
Interventions and Combinations of Interventions During the 
Actute Phase of Myocardial Infarction 
Initial Theraov 
Second Therapy 
Probability (if required 
for recurrent 
symptoms) 
I Year 
Mortality 
(%) 
Coronary artery bypass 
Angioplasty 
Angioplasty 
Angioplasty 
rt-PA 
rt-PA 
rt-PA 
Streptokinase 
Streptokinase 
Medical 
Streptokinase 
Coronary artery bypass 4.9 
Angioplasty 5.8 
Coronary artery bypass 6.1 
Medical 6.5 
Angioplasty 6.5 
Medical therapy 7.0 
Coronary artery bypass 7.0 
Medical 9.0 
Angioplasty 9.0 
Medical 10.1 
Coronary artery bypass 10.2 
&PA = recombinant tissue-type plasminogen activator. 
the lowest mortality rate of all strategies both in the hospital 
and at 1 year. Compared with medical therapy, the angio- 
plasty strategy reduced the 1 year mortality rate from 10.1 to 
5.8% and increased the 1 year complication-free survival 
rate from 58 to 71% at a cost, however, of $246,000 per life 
saved. The thrombolytic strategies (averaged between t-t-PA 
and streptokinase) reduced the mortality rate to 7.7% at a 
cost of $115,000 per life saved compared with medical 
therapy. 
Compared with the thrombolytic strategies, the angio- 
plasty strategy was more costly in 88% of patients, was more 
than double the cost in 24% of patients and had a marginal 
cost per life saved exceeding $400,000. In this model, 
angioplasty is an effective but expensive approach to care; 
thrombolytic therapy is a less expensive but effective alter- 
native. The policy issues that could be addressed by this 
model are obvious. 
Discussion 
Why physicians distrust decision modeling. Despite the 
advantages for policy making as well as for clinical decision 
making that may accrue through the use of decision model- 
ing, its application has been difficult to foster. 
Lack of physician acceptance has been a major factor in 
delaying incorporation of decision modeling into clinical 
medicine. Although part of the problem may be a lack of 
familiarity among physicians with the techniques, the major 
concerns are a mistrust of probability theory and what are 
conceived to be “made up ” data. 
The early infarction problem serves to illustrate why 
physicians have reservations about decision modeling. A 
decision model of the early myocardial infarction problems 
requires probabilities of death, congestive heart failure and 
lethal arrhythmias with and without intervention; probabili- 
ties of successful reperfusion; probabilities of significant 
myocardial salvage; probabilities of complications; probabil- 
ities of death from complications and probabilities of reoc- 
elusion. Furthermore, these need to be assigned for each 
strategy employed (medical therapy, streptokinase, rt-PA, 
angioplasty, coronary artery bypass surgery) and for multi- 
ple patient characteristics such as, age, gender, concomitant 
disease, left ventricular function, “culprit” artery, type of 
lesion and size of infarction that would be likely to result, 
among others. 
Physicians say the necessary data are simply not avail- 
able and they do not even want to play the game to get the 
point where the advantages to be gained from sensitivity 
analysis can be demonstrated. In addition, it is true that a 
decision model that incorporates all of the variables having 
predictive significance becomes quite complex, and estima- 
tion of the probabilities and utilities required to complete the 
structure becomes subject to increasing subjectivity and, 
potentially, decreasing reliability. 
Future requirements of decision modeling. If decision 
modeling is to achieve professional support, provisions must 
be made for the incorporation and validation of “real data,” 
such as those derived from clinical trials or observational 
data bases, or consensus derivations must be refined to the 
point of acceptability as alternatives for hard data. Until this 
happens, many physicians will continue to question the 
validity of the decision models, certainly relative to the 
individual patient care, but also, unfortunately, for socioeco- 
nomic purposes where the requirements for precise sub- 
group classifications may not be as stringent as for the 
management of the individual patient. 
A second problem that has delayed the growth and 
application of decision modeling is that it is costly, time- 
consuming and labor- and expertise-intensive. 
The problems of execution of decision modeling coupled 
with the concern among the participating cardiologists about 
data reliability have made the progress slow and the utility 
uncertain. Most government agencies or third party payers 
want an opinion on the effectiveness of technologic advances 
in a short period of time. They do not want to wait a year 
while a decision model is generated and tested for consen- 
sus. 
Summary 
Despite the problems, the rewards of the decision mod- 
eling technology in the present and projected economic and 
political climate can be great because any test or manage- 
ment strategy can be assigned a quantifiable “value” based 
on its contribution to clinical decision making and resultant 
patient outcome. 
There is no substitute for an informational approach to 
cost containment. Doctors, government and reimbursement 
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officials need vastly more information about medical costs as ongoing, appropriately funded and staffed operation. To 
related to the long- and short-term beneficial and detrimental achieve acceptability, the models must be data-driven either 
effects of alternative management strategies on patient out- by consensus derivation techniques or preferably by appro- 
come. priately analyzed observational data bases. 
Information needs to be provided as to which care 
practices are possible at given reimbursement rates and 
which effective practices would need to be foregone with 
alternative reimbursement decisions. We need to know if the 
trade-offs make sense for patients and for society, and we 
need a system flexible enough to enable us to act on this 
information. 
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